Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Other Non-Current Liabilities (2016 - 2020)

International Stem Cell (ISCO) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $40000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $40000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $40000.0, a N/A change, with the full-year FY2019 number at $207000.0, down 88.14% from a year prior.
  • Other Non-Current Liabilities was $40000.0 for Q3 2020 at International Stem Cell, down from $322000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $19.6 million in Q1 2016 to a low of $40000.0 in Q3 2020.
  • A 5-year average of $3.3 million and a median of $2.3 million in 2016 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: surged 755.65% in 2016, then crashed 91.55% in 2020.
  • International Stem Cell's Other Non-Current Liabilities stood at $2.0 million in 2016, then skyrocketed by 52.22% to $3.1 million in 2017, then crashed by 43.94% to $1.7 million in 2018, then crashed by 88.14% to $207000.0 in 2019, then crashed by 80.68% to $40000.0 in 2020.
  • Per Business Quant, the three most recent readings for ISCO's Other Non-Current Liabilities are $40000.0 (Q3 2020), $322000.0 (Q2 2020), and $97000.0 (Q1 2020).